Dawnrays Pharmaceutical (Holdings) Limited

Press Releases       


You will need the Adobe Acrobat Reader 7.0 and Asian Font Packs to view the PDF.
If you do not have any of the above, please download "Acrobat Reader" and
"Asian Font Packs for Acrobat Reader 7.0".

  • 2008-August-21
  • Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2008, Net Profit Jumped 18.2% to RMB 48.93 Million, an Interim Dividend of HK$ 0.018 per Share was Declared (in PDF)
  • 2008-May-15
  • Dawnrays Pharmaceutical (Holdings) Limited Donated Approximately RMB 1.2 Million Pharmaceuticals in Aid to the Earthquake-devastated Areas in Sichuan Province (in PDF)
  • 2008-March-17
  • Dawnrays Pharmaceutical (Holdings) Limited - AnNeiXi® - The First Generic New Compound Antihypertensive in China is Launched (in PDF)
  • 2008-March-17
  • Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2007: Net Profit Jumped 53.6% to RMB 101 Million, A Final Dividend of HK$ 0.038 Per Share was Declared (in PDF)
  • 2006
  • 2006 Press Releases
  • 2005
  • 2005 Press Releases


  • Company's Index
  • irasia.com

  • © Copyright 1996-2008 irasia.com Ltd. All rights reserved. Tel: (852) 2831-9792.
    DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website.
    TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited.
    TERMS OF USE: Please read the Terms of Use governing the use of our website.